More Like this

1. Classification of Neurological Gait Disorders Using Multi-task Feature Learning

   https://doi.org/10.1109/CHASE.2017.78  

   Papavasileiou, Ioannis; Zhang, Wenlong; Wang, Xin; Bi, Jinbo; Zhang, Li; Han, Song (July 2017, 2017 IEEE/ACM International Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE))

   As our population ages, neurological impairments and degeneration of the musculoskeletal system yield gait abnormalities, which can significantly reduce quality of life. Gait rehabilitative therapy has been widely adopted to help patients maximize community participation and living independence. To further improve the precision and efficiency of rehabilitative therapy, more objective methods need to be developed based on sensory data. In this paper, an algorithmic framework is proposed to provide classification of gait disorders caused by two common neurological diseases, stroke and Parkinson's Disease (PD), from ground contact force (GCF) data. An advanced machine learning method, multi-task feature learning (MTFL), is used to jointly train classification models of a subject's gait in three classes, post-stroke, PD and healthy gait. Gait parameters related to mobility, balance, strength and rhythm are used as features for the classification. Out of all the features used, the MTFL models capture the more important ones per disease, which will help provide better objective assessment and therapy progress tracking. To evaluate the proposed methodology we use data from a human participant study, which includes five PD patients, three post-stroke patients, and three healthy subjects. Despite the diversity of abnormalities, the evaluation shows that the proposed approach can successfully distinguish post-stroke and PD gait from healthy gait, as well as post-stroke from PD gait, with Area Under the Curve (AUC) score of at least 0.96. Moreover, the methodology helps select important gait features to better understand the key characteristics that distinguish abnormal gaits and design personalized treatment. 

   more » « less
2. A pilot study of the Earable device to measure facial muscle and eye movement tasks among healthy volunteers

   https://doi.org/10.1371/journal.pdig.0000061  

   Wipperman, Matthew F.; Pogoncheff, Galen; Mateo, Katrina F.; Wu, Xuefang; Chen, Yiziying; Levy, Oren; Avbersek, Andreja; Deterding, Robin R.; Hamon, Sara C.; Vu, Tam; et al (June 2022, PLOS Digital Health)

   Li-Jessen, Nicole Yee-Key (Ed.)

   The Earable device is a behind-the-ear wearable originally developed to measure cognitive function. Since Earable measures electroencephalography (EEG), electromyography (EMG), and electrooculography (EOG), it may also have the potential to objectively quantify facial muscle and eye movement activities relevant in the assessment of neuromuscular disorders. As an initial step to developing a digital assessment in neuromuscular disorders, a pilot study was conducted to determine whether the Earable device could be utilized to objectively measure facial muscle and eye movements intended to be representative of Performance Outcome Assessments, (PerfOs) with tasks designed to model clinical PerfOs, referred to as mock-PerfO activities. The specific aims of this study were: To determine whether the Earable raw EMG, EOG, and EEG signals could be processed to extract features describing these waveforms; To determine Earable feature data quality, test re-test reliability, and statistical properties; To determine whether features derived from Earable could be used to determine the difference between various facial muscle and eye movement activities; and, To determine what features and feature types are important for mock-PerfO activity level classification. A total of N = 10 healthy volunteers participated in the study. Each study participant performed 16 mock-PerfOs activities, including talking, chewing, swallowing, eye closure, gazing in different directions, puffing cheeks, chewing an apple, and making various facial expressions. Each activity was repeated four times in the morning and four times at night. A total of 161 summary features were extracted from the EEG, EMG, and EOG bio-sensor data. Feature vectors were used as input to machine learning models to classify the mock-PerfO activities, and model performance was evaluated on a held-out test set. Additionally, a convolutional neural network (CNN) was used to classify low-level representations of the raw bio-sensor data for each task, and model performance was correspondingly evaluated and compared directly to feature classification performance. The model’s prediction accuracy on the Earable device’s classification ability was quantitatively assessed. Study results indicate that Earable can potentially quantify different aspects of facial and eye movements and may be used to differentiate mock-PerfO activities. Specially, Earable was found to differentiate talking, chewing, and swallowing tasks from other tasks with observed F1 scores >0.9. While EMG features contribute to classification accuracy for all tasks, EOG features are important for classifying gaze tasks. Finally, we found that analysis with summary features outperformed a CNN for activity classification. We believe Earable may be used to measure cranial muscle activity relevant for neuromuscular disorder assessment. Classification performance of mock-PerfO activities with summary features enables a strategy for detecting disease-specific signals relative to controls, as well as the monitoring of intra-subject treatment responses. Further testing is needed to evaluate the Earable device in clinical populations and clinical development settings. 

   more » « less
3. Merging fNIRS-EEG Brain Monitoring and Body Motion Capture to Distinguish Parkinson’s Disease

   https://doi.org/10.1109/TNSRE.2020.2987888  

   Abtahi, Mohammadreza; Borgheai, Seyed Bahram; Jafari, Roohollah; Constant, Nicholas; Diouf, Rassoul; Shahriari, Yalda; Mankodiya, Kunal (January 2020, IEEE Transactions on Neural Systems and Rehabilitation Engineering)

   Functional connectivity between the brain and body kinematics has largely not been investigated due to the requirement of motionlessness in neuroimaging techniques such as functional magnetic resonance imaging (fMRI). However, this connectivity is disrupted in many neurodegenerative disorders, including Parkinson’s Disease (PD), a neurological progressive disorder characterized by movement symptoms including slowness of movement, stiffness, tremors at rest, and walking and standing instability. In this study, brain activity is recorded through functional near-infrared spectroscopy (fNIRS) and electroencephalography (EEG), and body kinematics were captured by a motion capture system (Mocap) based on an inertial measurement unit (IMU) for gross movements (large movements such as limb kinematics), and the WearUp glove for fine movements (small range movements such as finger kinematics). PD and neurotypical (NT) participants were recruited to perform 8 different movement tasks. The recorded data from each modality have been analyzed individually, and the processed data has been used for classification between the PD and NT groups. The average changes in oxygenated hemoglobin (HbO2) from fNIRS, EEG power spectral density in the Theta, Alpha, and Beta bands, acceleration vector from Mocap, and normalized WearUp flex sensor data were used for classification. 12 different support vector machine (SVM) classifiers have been used on different datasets such as only fNIRS data, only EEG data, hybrid fNIRS/EEG data, and all the fused data for two classification scenarios: classifying PD and NT based on individual activities, and all activity data fused together. The PD and NT group could be distinguished with more than 83% accuracy for each individual activity. For all the fused data, the PD and NT groups are classified with 81.23%, 92.79%, 92.27%, and 93.40% accuracy for the fNIRS only, EEG only, hybrid fNIRS/EEG, and all fused data, respectively. The results indicate that the overall performance of classification in distinguishing PD and NT groups improves when using both brain and body data. 

   more » « less
4. Design and Development of a Haptic BCI

   Ganesan, Karthikeyan; Mahalingam, Karthiga; Jackson, Melody Moore (May 2021, Abstract Book of the 8th International Brain-Computer Interface Meeting)

   Brain Computer Interfaces (BCIs) traditionally deploy visual or auditory stimuli to elicit brain signals. However, these stimuli are not very useful in situations where the visual or auditory senses are involved in other decision making processes. In this paper, we explore the use of vibrotactile stimuli on the fi ngers as a viable replacement. Using a fi ve-level Wavelet Packet feature extraction on the obtained EEG signals, along with a kernel Support Vector Machine (SVM) algorithm, we were able to achieve 83% classi cation accuracy for binary user choices. This new BCI paradigm shows potential for use in situations where visual and auditory stimuli are not feasible. 

   more » « less
5. Predicting Treatment Outcome in Spinal Cord Stimulation with EEG

   See, Kyle; July, Rachel; Coombes, Stephen; Fang, Ruogu (October 2021, Biomedical Engineering Society Annual Meeting)

   Introduction: Back pain is one of the most common causes of pain in the United States. Spinal cord stimulation (SCS) is an intervention for patients with chronic back pain (CBP). However, SCS decreases pain in only 58% of patients and relies on self-reported pain scores as outcome measures. An SCS trial is temporarily implanted for seven days and helps to determine if a permanent SCS is needed. Patients that have a >50% reduction in pain from the trial stimulator makes them eligible for permanent implantation. However, self-reported measures reveal little on how mechanisms in the brain are altered. Other measurements of pain intensity, onset, medication, disabilities, depression, and anxiety have been used with machine learning to predict outcomes with accuracies <70%. We aim to predict long-term SCS responders at 6-months using baseline resting EEG and machine learning. Materials and Methods: We obtained 10-minutes of resting electroencephalography (EEG) and pain questionnaires from nine participants with CBP at two time points: 1) pre-trial baseline. 2) Six months after SCS permanent implant surgery. Subjects were designated as high or moderate responders based on the amount of pain relief provided by the long-term (post six months) SCS, and pain scored on a scale of 0-10 with 0 being no pain and 10 intolerable. We used the resting EEG from baseline to predict long-term treatment outcome. Resting EEG data was fed through a pipeline for classification and to map dipole sources. EEG signals were preprocessed using the EEGLAB toolbox. Independent component analysis and dipole fitting were used to linearly unmix the signal and to map dipole sources from the brain. Spectral analysis was performed to obtain the frequency distribution of the signal. Each power band, delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and gamma (30-100 Hz), as well as the entire spectrum (1-100 Hz), were used for classification. Furthermore, dipole sources were ranked based on classification feature weights to determine the significance of specific regions in the brain. We used support vector machines to predict pain outcomes. Results and Discussion: We found higher frequency powerbands provide overall classification performance of 88.89%. Differences in power are seen between moderate and high responders in both the frontal and parietal regions for theta, alpha, beta, and the entire spectrum (Fig.1). This can potentially be used to predict patient response to SCS. Conclusions: We found evidence of decreased power in theta, alpha, beta, and entire spectrum in the anterior regions of the parietal cortex and posterior regions of the frontal cortex between moderate and high responders, which can be used for predicting treatment outcomes in long-term pain relief from SCS. Long-term treatment outcome prediction using baseline EEG data has the potential to contribute to decision making in terms of permanent surgery, forgo trial periods, and improve clinical efficiency by beginning to understand the mechanism of action of SCS in the human brain. 

   more » « less